Humana executive exercises options, withholds shares

Humana Inc. President, Insurance George Renaudin II reported option-related activity in Humana common stock.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Humana Inc. President, Insurance George Renaudin II reported option-related activity in Humana common stock. On 02/24/2026, he acquired 1,035 shares through an exercise of stock options and disposed of 419 shares at $177.075 per share to cover tax liabilities on performance stock vesting, receiving no cash value in return.

Insider Trade Summary

6 transactions reported

Mixed 6 txns

Insider Renaudin George II

Role President, Insurance

Type	Security	Shares	Price	Value
Exercise	Humana Common	1,035	$0.00	$0.00
Exercise Price or Tax Liability	Humana Common	419	$177.075	$74K
holding	Options	--	--	--
holding	Options	--	--	--
holding	Phantom Stock Units	--	--	--
holding	Humana Common	--	--	--

Holdings After Transaction: Humana Common — 16,075 shares (Direct); Options — 11,128 contracts (Direct); Phantom Stock Units — 174 contracts (Indirect, See Footnote); Humana Common — 529 shares (Indirect, See Footnote)

Footnotes (7)

F1. Shares held for the benefit of reporting person as of January 31, 2026 under the Humana Retirement Savings Plan including routine payroll deductions, quarterly dividend allocation, and a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan, exempt under Rule 16b-3(c).
F2. Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26.
F3. Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.
F4. Includes 9,059 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.
F5. Phantom Stock Units held for the benefit of reporting person as of January 31, 2026 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. Contributions are made once annually and reported within 2 business days of the contribution date with the transaction code "J". The ending number of units reflects normal fluctuation due to changes in stock price.
F6. Includes Performance Stock Units not required to be reported until vesting on 2/24/26.
F7. Shares disposed of represent payment for tax liability on performance stock vesting on 2/24/26. No value was received in return.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Humana (HUM) executive George Renaudin report in this Form 4?

George Renaudin reported option-related transactions in Humana common stock. He exercised stock options to acquire 1,035 shares and disposed of 419 shares to satisfy tax liabilities related to performance stock vesting, with no cash value received for the tax-withholding shares.

How many Humana shares did George Renaudin acquire and dispose of?

He acquired 1,035 Humana common shares through an option exercise and disposed of 419 shares as payment of tax liability on performance stock vesting. The tax-related disposition used shares valued at $177.075 each, rather than cash, to cover the obligation.

Was George Renaudin’s Humana Form 4 transaction an open-market buy or sale?

The filing shows an option exercise and a tax-withholding disposition, not open-market trading. Shares were acquired via stock option exercise and 419 shares were delivered back to cover tax obligations on vested performance stock, with no sale proceeds paid to the executive.

What does the Form 4 say about George Renaudin’s remaining Humana holdings?

After these transactions, Renaudin directly held 16,075 Humana common shares. The filing also notes option positions and equity awards, including 9,059 restricted stock units and performance stock units that are not required to be reported until vesting on February 24, 2026.

How are phantom stock units described in George Renaudin’s Humana filing?

Phantom stock units are held for his benefit under the Humana Retirement Equalization Plan on a 1-for-1 value basis with Humana common stock. Contributions occur annually and are reported with transaction code “J”; the ending unit balance fluctuates with changes in Humana’s stock price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 02/26/2026 - 03:43 PM EST

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Renaudin George II

(Last)

(First)

(Middle)

HUMANA INC.

101 E. MAIN STREET

(Street)

LOUISVILLE

40202

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
HUMANA INC [ HUM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President, Insurance

3. Date of Earliest Transaction (Month/Day/Year)
02/24/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Humana Common	02/24/2026		M		1,035⁽⁶⁾	A	$0	16,494	D
Humana Common	02/24/2026		F		419⁽⁷⁾	D	$177.075	16,075⁽⁴⁾	D
Humana Common								529	I	See Footnote⁽¹⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Options⁽²⁾	$510.2425							⁽²⁾	02/24/2030	Humana Common	4,162		4,162	D
Options⁽³⁾	$367.21							⁽³⁾	02/21/2031	Humana Common	6,966		6,966	D
Phantom Stock Units⁽⁵⁾	⁽⁵⁾							⁽⁵⁾	⁽⁵⁾	Humana Common	174		174	I	See Footnote⁽⁵⁾

Explanation of Responses:

1. Shares held for the benefit of reporting person as of January 31, 2026 under the Humana Retirement Savings Plan including routine payroll deductions, quarterly dividend allocation, and a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan, exempt under Rule 16b-3(c).

2. Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26.

3. Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.

4. Includes 9,059 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

5. Phantom Stock Units held for the benefit of reporting person as of January 31, 2026 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. Contributions are made once annually and reported within 2 business days of the contribution date with the transaction code "J". The ending number of units reflects normal fluctuation due to changes in stock price.

6. Includes Performance Stock Units not required to be reported until vesting on 2/24/26.

7. Shares disposed of represent payment for tax liability on performance stock vesting on 2/24/26. No value was received in return.

	George Renaudin II	02/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR